By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Liver revenue460.53M76.06%
Heart revenue126.01M20.81%
Lung revenue14.86M2.45%
Service revenue unrelated to Organ Care System (OCS) transplant4.1M0.68%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States584.7M96.56%
All other countries16.7M2.76%
Service revenue unrelated to Organ Care System (OCS) transplant4.1M0.68%